Newly discovered epidermal growth factor receptor active in human pancreatic cancers
Sunday, April 19, 2009 - 13:42
in Health & Medicine
Finally some promising news about pancreatic cancer, one of the most fatal cancers, due to the difficulties of early detection and the lack of effective therapies: Johns Hopkins University pathologist Akhilesh Pandey has identified an epidermal growth factor receptor aberrantly active in approximately a third of the 250 human pancreatic cancers studied.
Read the whole article on Physorg
More from Physorg
Related
- Newly discovered epidermal growth factor receptor active in human pancreatic cancersSat, 18 Apr 2009, 12:43:05 EDT
- A promising approach in the prevention and treatment of pancreatic cancerThu, 25 Sep 2008, 9:43:12 EDT
- Experimental insulin-like growth factor receptor inhibitor reduced pancreatic cancer growthTue, 14 Apr 2009, 13:49:41 EDT
- Which is promising as therapeutic targets in patients with biliary tract cancer? EGFR or HER2?Fri, 16 Oct 2009, 9:45:14 EDT
- New drug achieves pancreatic cancer tumor remission and prevents recurrenceSun, 19 Apr 2009, 15:29:49 EDT